Phone: +1 203 650 0415
Fax: + 1 917 634 3035
Fletcher W. Moore specializes in civil litigation. Mr. Moore has handled jury trials, bench trials, argued in appellate courts, and conducted extensive fact-based hearings with numerous witnesses in open court. He focuses his practice in securities, commercial, and personal injury litigation. He has represented corporations and individuals in cases involving securities, shareholder rights, partnership disputes, consumer class actions, mass torts, sexual assault, and serious physical injuries. He also counsels clients on licensing, SaaS, GDPR compliance, employment, trademarks, and creditors’ rights.
Mr. Moore has handled cases in state and federal courts all over Connecticut, New York, New Jersey, and Pennsylvania. He has published articles nationally on drug litigation, class actions and other topics of current interest, and has been extensively involved in pro bono matters representing multiple prisoners in federal civil rights actions.
Before founding a law firm, Mr. Moore spent several years as an attorney with a large international law firm.
- Representing broker-dealer specializing in hybrid securities against claims of aiding and abetting, breach of fiduciary duty, unjust enrichment and fraudulent transfer.
- Representing wealth management and investment advisor against claims of misrepresentation and civil conspiracy arising out of a third-party agreement to sell a former agent’s book of business.
- Representing corporate parent of nursing-home system against claims of breach of contract and unjust enrichment.
- Represented private security company asserting claims of breach of contract and guaranty against its joint-venture partner, while defending against counterclaims of breach of contract and fraud.
- Advised broker-dealer on its rights and obligations under its corporate officer agreement with respect to corporate officer indemnification.
- Defending a commercial property owner in an action for breach of contract brought on behalf of the property’s seller and asserting counterclaims for fraudulent inducement.
- Representing class of dentists and periodontists asserting claims for breach of warranty and consumer fraud against major manufacturer of dental products.
- Defending mass tort cases on behalf of pharmaceutical manufacturers in failure-to-warn personal injury litigation in state and federal courts.
- Represented group of generic pharmaceutical manufacturers, appearing as amici curiae, in failure-to-warn personal injury litigation pending in the Superior Court of New Jersey, Appellate Division.
- Represented managers of limited liability partnership seeking to validate management elections under Delaware law.
- New York
- U.S. District Court for the Eastern District of Pennsylvania
- U.S. District Court for the Southern District of New York
- U.S. District Court for the District of Connecticut
- New York Law School, J.D., 2009
- University of Connecticut, B.A., 2004
- Duane Morris LLP
- Houser & Allison
- Eckert Seamans Cherin & Mellot LLC
- Co-author, “Supreme Court Orders Ninth Circuit to Revisit Preemption Ruling Against Generic OTC Ibuprofen Manufacturer,” Duane Morris Alert, November 2, 2011; republished by Linex Systems, November 3, 2011; republished in Product Liability Law360, November 8, 2011
- Co-author, “Big Win for Drug Companies Under the New Jersey Product Liability Act,” Duane Morris Alert, October 4, 2011; republished by Linex Systems, October 2011; republished in·Product Liability Law360, November 15, 2011
- Co-author, “Pennsylvania District Court Dismisses Class Action Against Pharmaceutical Giant Johnson & Johnson,” Duane Morris Alert, July 26, 2011; republished in Product Liability Law360, September 28, 2011
- Co-author, “U.S. Supreme Court Holds That State-Law-Based Failure-to-Warn Claims Are Federally Preempted Against Generic Drug Manufacturers,” Duane Morris Alert, June 23, 2011
- Co-author, “In Smith v. Bayer Corp., Supreme Court Breathes New Life into Repetitive State Court Class Actions,” Duane Morris Alert, June 23, 2011
- Co-author, “In Pennsylvania Products Liability Decisions, Pharmaceutical Manufacturers May Lose a Little, but Gain a Lot,” Health Lawyers Weekly by American Health Lawyers Association, August 27, 2010; Product Liability Law360 and HealthLaw360 by Portfolio Media, Inc., September 1, 2010